⌘K

Login Start Free

Home/Filings/4/0001215906-03-000001

4//SEC Filing

GEHLSEN KURT R 4

Accession 0001215906-03-000001

CIK 0001013351other

View on SEC.gov Company Profile

Filed

Nov 23, 7:00 PM ET

Accepted

Nov 24, 4:12 PM ET

Size

5.7 KB

Accession

0001215906-03-000001

Insider Transaction Report

Form 4

Period: 2003-11-20

MAXIM PHARMACEUTICALS INCMAXM

Chief Scientific Officer

Transactions

Award
Option to Purchase (NSO)
2003-11-20$6.72/sh+25,000$168,000→ 25,000 total
Exercise: $6.72Exp: 2013-11-20→ Common Stock (25,000 underlying)

Footnotes (1)

[F1]F1 1/4 of the shares vest annually beginning one year after the transaction date.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

MAXIM PHARMACEUTICALS INC

CIK 0001013351

Entity typeother

Related Parties

1

filerCIK 0001215906

Filing Metadata

Form type: 4
Filed: Nov 23, 7:00 PM ET
Accepted: Nov 24, 4:12 PM ET
Size: 5.7 KB

View on SEC.gov